MedPath

MiVacunaLA: an Intervention to Improve COVID-19 Vaccination Behaviors Among Latinos

Not Applicable
Completed
Conditions
COVID-19 Pandemic
Interventions
Behavioral: mivacunaLA
Registration Number
NCT05234372
Lead Sponsor
University of California, Los Angeles
Brief Summary

The aim of this study is to determine whether a community-informed, linguistically and culturally tailored educational program delivered via mobile phone is effective in improving vaccination behaviors among Latino families. Thus we evaluate a community-based mobile phone intervention (mivacunaLA) to assess if there is an increase in vaccination rates among 12-17 year old children and willingness to vaccinate 2-11year old children who have not been previously vaccinated who reside in high-risk and low resourced neighborhoods in Los Angeles.

Detailed Description

We conducted a community-based randomized clinical trial with a wait list control group among adult Latino parents or caregivers in East and South Los Angeles. Participants completed an online demographic and baseline survey and were randomly assigned to treatment or wait-list control. Based on their preference, participants received a weekly text message or email link twice a week for four weeks (Mon and Wed at noon). Twice a week messages consisted of a short text (\<160 characters) linking participants to a 2-3 minute video (Monday) and educational text (around 500 words in length. The material was divided into weekly topics regarding the coronavirus vaccine and other topics relevant to the Latino community. Participants were also directed to reliable websites where they could access additional information and links with instructions on where to get vaccinated. Upon completing the intervention, participants completed a 1-month follow-up survey.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
468
Inclusion Criteria
  1. self-identified as Latino/a,
  2. were 18 years or older,
  3. had at least one unvaccinated child of any age (17 or younger), and
  4. had the means to receive messages and review educational material online, such as a text-capable mobile phone with internet access
Exclusion Criteria
  1. Unable to receive information via mobile text or computer.
  2. Does not speak English or Spanish.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Treatment received intervention at enrollmentmivacunaLAParticipants received mobile phone delivered intervention at enrollment. The intervention had a duration of 4 weeks. Each week participants received two text messages inviting them to view a short video (Monday) and brief written content (Wed). Each week, the material consisted of a culturally tailored theme related to COVID-19 vaccination. Participants also received information on how to get vaccinated.
ControlmivacunaLAWait-list control. No intervention during month 1. Received the intervention at Month 2. Each week, during the first month, participants received a text with a count down of how many days were left to begin the intervention.
Primary Outcome Measures
NameTimeMethod
Primary Outcome Measure: vaccination status among minors 12-17 years1 month

Changes in COVID-19 vaccination status among minors 12-17 years. Have the minor #X 12-17 years old in your household been vaccinated for the coronavirus? 1.Yes, 2.No, 3.Unsure Instrument similar used in the Understanding America Study

Intent to vaccinate children 2-11 yrs old1 month

Change in willingness to vaccinate children 2-11 yrs old. f a vaccine against the coronavirus becomes available for children ages 2-11, do you plan to get them vaccinated?1.Yes, as soon as possible, 2.Yes, but I want to wait and see, 3.No, but I want to wait and see, 4.No, I will not get a coronavirus vaccine for my child, 5.Not sure. Positive answers:1.Yes, as soon as possible, 2.Yes, but I want to wait and see Not positive: 3.No, but I want to wait and see, 4.No, I will not get a coronavirus vaccine for my child, 5.Not sure Instrument adjusted from Understanding America Study.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

University of California Los Angeles

🇺🇸

Los Angeles, California, United States

Pepperdine University

🇺🇸

Malibu, California, United States

© Copyright 2025. All Rights Reserved by MedPath